Medical Communications

It seems that an appointment in Trump’s administration cannot avoid being a topic of some controversy. That’s the case with …

Sanofi’s Riccardo Perfetti, Head of Global Diabetes, and Jukka Westerbacka, Medical Director, Global Medical Affairs, discuss how the significance of …

AstraZeneca announced a new Managing Director for AstraZeneca Pharma India, with Gagan Singh Bedi beginning the role on 3 July. …

It’s Friday, and we’ve brought together our weekly digest of the articles which proved most popular with our readers. Brexit …

Those commentating on Celgene’s latest deal seem to be equally divided between two camps: it is too much money, too …

This article was originally published in Pharmafile Spring 2017.Opdivo and Revlimid to compete for the top spot in 2022, while …

Despite increasing controversy arising over the years due to the questionable relationship between physicians and pharma and the money which …

Following on from the news last month that enrolment for Keytruda being used alongside Celgene’s Imnovid and Revlimid would have …

Merck KGaA announced that is has created the Merck Foundation and has appointed Rasha Kelej as its CEO. The role …

The EMA and the FDA have announced that they have developed a joint proposal to promote more efficient means of …

DeepMind’s deal with the NHS to develop an app that is able to detect possible kidney damage involved 1.6 million …

When they first came along, webinars were the equivalent of an outside broadcast unit, lots of hardware, dedicated studios and …

Jeremy Hunt, Health Secretary, and Greg Clark, Business Secretary, have made a bold move to suggest that the UK will …

The development of innovative treatments for neurological disorders such as dementia has stagnated over the past decade despite being an …

Following on from the success of our previous free webinar sessions, Pharmafocus is partnering